Patients Professionals Professional oportunities About Novo Nordisk Contact Spain Novo Nordisk Spain / Patients Patients Diabetes Haemostasis Growth hormone Obesity Novo Nordisk in Spain Novo Nordisk is the world leader in the treatment of diabetes. It offers the most complete range of diabetes products in the pharmaceutical industry, including the most advanced insulin delivery systems preferred by patients and healthcare professionals. In addition, Novo Nordisk stands in a prominent position in other therapeutic areas, such as hemostasis, growth hormone, and now also in obesity. Novo Nordisk produces and markets products and services aimed at improving the quality of life of patients, healthcare professionals and society in general. Diabetes Diabetes is a chronic disease characterized by the presence of high levels of glucose in the blood. Read more Obesity Obesity is a chronic, complex and multifactorial disease, in which physiological, psychological, environmental, socioeconomic and genetic factors intervene. Read more Haemostasis Hemophilia is a congenital or acquired bleeding disorder caused by a deficiency of factor VIII coagulation (hemophilia A) or factor IX (hemophilia B). Read more Growth hormone Novo Nordisk is one of the world's leading manufacturers of biosynthetic growth hormone. Read more About us Con sede en Dinamarca, Novo Nordisk es una compañía global de cuidados sanitarios y más de 90 años de innovación y liderazgo en diabetes. La compañía también ostenta posiciones de liderazgo en el cuidado de la hemofilia y los trastornos del crecimiento. Novo Nordisk emplea aproximadamente a 41.500 personas en 75 países, y comercializa sus productos en más de 180 países. Páginas webs Novo Nordisk NovoNordisk.com O seleccionee: Otros Paises Otros sitios Novo Nordisk en el mundo Mapa, direcciones e información de ruta © 2015 Copyright Novo Nordisk Pharma, S.A. Aviso Legal